Recent Quarter Total Invested
$1.74 B
Recent Quarter Institutional Ownership Percentage
93.39%
Total Invested of Last Quarter
$781.17 M
Ownership Percentage of Last Quarter
79.01%
Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/15/2024 | 19.96 M | $319.21 M | 0.00% | 17.17% |
| GENERAL ATLANTIC, L.P. | 11/12/2024 | 9.68 M | $154.81 M | 0.00% | 8.33% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 6.28 M | $100.45 M | 59.72% | 5.40% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 5.94 M | $94.98 M | 24.26% | 5.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.68 M | $74.82 M | 32.54% | 4.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 4.20 M | $67.08 M | 34.24% | 3.61% |
| VIDA VENTURES ADVISORS, LLC | 10/08/2024 | 3.93 M | $62.87 M | 0.00% | 3.38% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 3.56 M | $56.86 M | 326.39% | 3.06% |
| SIREN, L.L.C. | 11/13/2024 | 3.26 M | $52.11 B | 100.00% | 2.80% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 3.22 M | $51.55 M | -43.58% | 2.77% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 2.89 M | $46.22 M | 0.00% | 2.49% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.81 M | $45.00 M | 41.00% | 2.42% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.72 M | $43.42 M | 54.12% | 2.34% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 2.56 M | $40.96 M | 58.95% | 2.20% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 2.30 M | $38.36 M | 99.06% | 1.98% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.16 M | $34.57 M | 3.33% | 1.86% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 2.13 M | $34.09 M | 100.00% | 1.83% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 2.01 M | $32.17 M | -14.20% | 1.73% |
| MORGAN STANLEY | 11/14/2024 | 1.38 M | $22.06 M | -32.71% | 1.19% |
| COMMODORE CAPITAL LP | 11/14/2024 | 1.35 M | $21.59 M | 100.00% | 1.16% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 1.35 M | $21.59 M | 100.00% | 1.16% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.29 M | $20.70 M | 100.00% | 1.11% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 1.29 M | $20.55 M | 3.21% | 1.11% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.23 M | $19.62 M | 123.44% | 1.06% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.14 M | $18.22 M | 21.86% | 0.98% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 965,612 | $15.44 M | -14.98% | 0.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 744,592 | $11.91 M | 100.00% | 0.64% |
| TANAGER WEALTH MANAGEMENT LLP | 10/22/2024 | 696,096 | $11.13 M | 0.00% | 0.60% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 681,421 | $10.90 M | -33.40% | 0.59% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 640,000 | $10.23 M | 100.00% | 0.55% |
| CITADEL ADVISORS LLC | 11/14/2024 | 587,518 | $9.39 M | 1,434.95% | 0.51% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 559,720 | $8.95 M | 100.00% | 0.48% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 558,714 | $8.82 M | 73.96% | 0.48% |
| WOODLINE PARTNERS LP | 11/14/2024 | 516,379 | $8.26 M | 318.25% | 0.44% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 512,647 | $8.20 M | 13.92% | 0.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 429,701 | $6.87 M | -13.35% | 0.37% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 400,000 | $6.40 M | 100.00% | 0.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 313,338 | $5.01 M | 327.61% | 0.27% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 309,614 | $4.95 M | 100.00% | 0.27% |
| LORD, ABBETT & CO. LLC | 11/14/2024 | 269,205 | $4.31 M | 100.00% | 0.23% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 269,158 | $4.30 M | -57.66% | 0.23% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 264,969 | $4.24 M | 88.06% | 0.23% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 255,000 | $4.08 M | 100.00% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 230,379 | $3.68 M | 365.55% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 209,600 | $3.35 M | 20.67% | 0.18% |
| MARSHALL WACE, LLP | 11/14/2024 | 180,853 | $2.89 M | -19.60% | 0.16% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 177,553 | $2.84 M | 1,515.15% | 0.15% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 170,951 | $2.73 M | 290.76% | 0.15% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/17/2024 | 167,135 | $2.67 M | 79.72% | 0.14% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 161,293 | $2.58 M | 56.31% | 0.14% |
Centessa Pharmaceuticals plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CNTA shares?
During the previous two years, 111 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 19.96 M
GENERAL ATLANTIC, L.P.: 9.68 M
PERCEPTIVE ADVISORS LLC: 6.28 M
First Light Asset Management, LLC: 5.94 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.68 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.2 M
-
What percentage of Centessa Pharmaceuticals plc stock is owned by institutional investors?
93.39% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
-
How much institutional buying is happening at CNTA ?
Institutional investors have bought a total of 118.83 M shares in the last 24 months. This purchase volume represents approximately $2.16 B in transactions.